Disclaimer:
Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.
Amlodipine and Valsartan
Overview
What is Amlodipine and Valsartan?
Amlodipine and valsartan tablets, USP are fixed combination of amlodipine and valsartan.Amlodipine and valsartan tablets, USP contains the besylate salt of amlodipine, a dihydropyridine calcium-channel blocker (CCB). Amlodipine besylate is a white or almost white powder, slightly soluble in water and sparingly soluble in ethanol. Amlodipine besylate’s chemical name is 3-Ethyl-5-methyl(4RS)-2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate benzenesulphonate; its structural formula is
Its empirical formula is CHClNO•CHOS and its molecular weight is 567.1.
Valsartan is a nonpeptide, orally active, and specific angiotensin II antagonist acting on the AT1 receptor subtype. Valsartan is white or almost white hygroscopic powder, freely soluble in anhydrous ethanol; sparingly soluble in methylene chloride; practically insoluble in water.
Valsartan’s chemical name is N-(1-oxopentyl)-N-[[2’-(1H-tetrazol-5-yl)[1,1’-biphenyl]-4-yl]methyl]-L-valine; its structural formula is
Its empirical formula is CHNO and its molecular weight is 435.5. Amlodipine and valsartan tablets, USP are formulated in four strengths for oral administration with a combination of amlodipine besylate, equivalent to 5 mg or 10 mg of amlodipine free-base, with 160 mg, or 320 mg of valsartan providing for the following available combinations: 5/160 mg, 10/160 mg, 5/320 mg, and 10/320 mg.
The inactive ingredients for all strengths of the tablets are colloidal silicon dioxide, crospovidone, magnesium stearate and microcrystalline cellulose. Additionally the 5/160 mg and 5/320 mg strengths contain iron oxide red. The film coating contains hypromellose, iron oxide yellow, polyethylene glycol, talc and titanium dioxide.
What does Amlodipine and Valsartan look like?










What are the available doses of Amlodipine and Valsartan?
Sorry No records found.
What should I talk to my health care provider before I take Amlodipine and Valsartan?
Sorry No records found
How should I use Amlodipine and Valsartan?
Dose once daily. The dosage can be increased after 1 to 2 weeks of therapy to a maximum of one 10/320mg tablet once daily as needed to control blood pressure. The majority of the antihypertensive effect is attained within 2 weeks after initiation of therapy or a change in dose. Amlodipine and valsartan tablets may be administered with or without food. Amlodipine and valsartan tablets may be administered with other antihypertensive agents.
What interacts with Amlodipine and Valsartan?
Sorry No Records found
What are the warnings of Amlodipine and Valsartan?
Sorry No Records found
What are the precautions of Amlodipine and Valsartan?
Sorry No Records found
What are the side effects of Amlodipine and Valsartan?
Sorry No records found
What should I look out for while using Amlodipine and Valsartan?
What might happen if I take too much Amlodipine and Valsartan?
Amlodipine
Single oral doses of amlodipine maleate equivalent to 40 mg/kg and 100 mg/kg amlodipine in mice and rats, respectively, caused deaths. Single oral doses equivalent to 4 or more mg/kg amlodipine in dogs (11 or more times the maximum recommended human dose on a mg/mbasis) caused a marked peripheral vasodilation and hypotension.
Overdosage might be expected to cause excessive peripheral vasodilation with marked hypotension. In humans, experience with intentional overdosage of amlodipine is limited. Marked and potentially prolonged systemic hypotension up to and including shock with fatal outcome have been reported.
If massive overdose should occur, initiate active cardiac and respiratory monitoring. Frequent blood pressure measurements are essential. Should hypotension occur, cardiovascular support including elevation of the extremities and the judicious administration of fluids should be initiated. If hypotension remains unresponsive to these conservative measures, consider administration of vasopressors (such as phenylephrine) with attention to circulating volume and urine output. As amlodipine is highly protein bound, hemodialysis is not likely to be of benefit. Administration of activated charcoal to healthy volunteers immediately or up to two hours after ingestion of amlodipine has been shown to significantly decrease amlodipine absorption.
Valsartan
Limited data are available related to overdosage in humans. The most likely effect of overdose with valsartan would be peripheral vasodilation, hypotension, and tachycardia; bradycardia could occur from parasympathetic (vagal) stimulation. Depressed level of consciousness, circulatory collapse, and shock have been reported. If symptomatic hypotension should occur, supportive treatment should be instituted.
Valsartan is not removed from the plasma by hemodialysis.
Valsartan was without grossly observable adverse effects at single oral doses up to 2000 mg/kg in rats and up to 1000 mg/kg in marmosets, except for the salivation and diarrhea in the rat and vomiting in the marmoset at the highest dose (60 and 37 times, respectively, the maximum recommended human dose (MRHD) on a mg/mbasis). (Calculations assume an oral dose of 320 mg/day and a 60-kg patient.)
How should I store and handle Amlodipine and Valsartan?
Store at 20° to 25°C (68° to 77°F); excursions permitted from 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Amlodipine and valsartan tablets, USP are available as non-scored tablets containing amlodipine besylate equivalent to 5 mg, or 10 mg of amlodipine free-base with valsartan 160 mg or 320 mg, providing for the following available combinations: 5/160 mg, 10/160 mg, 5/320 mg and 10/320 mg.All strengths are packaged in bottles of 30, 90, 100 and 500 counts, and unit dose packages. 5/160 mg Tablets - dark yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L298’ on one side and plain on other side. Bottles of 30 NDC # 46708-458-30 Bottles of 90 NDC # 46708-458-90Bottles of 100 NDC # 46708-458-31Bottles of 500 NDC # 46708-458-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-458-1010/160 mg Tablets - light yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L300’ on one side and plain on other side. Bottles of 30 NDC # 46708-459-30 Bottles of 90 NDC # 46708-459-90Bottles of 100 NDC # 46708-459-31Bottles of 500 NDC # 46708-459-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-459-105/320 mg Tablets - dark yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L299’ on one side and plain on other side. Bottles of 30 NDC # 46708-460-30 Bottles of 90 NDC # 46708-460-90Bottles of 100 NDC # 46708-460-31Bottles of 500 NDC # 46708-460-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-460-1010/320 mg Tablets - light yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L301’ on one side and plain on other side. Bottles of 30 NDC # 46708-461-30 Bottles of 90 NDC # 46708-461-90Bottles of 100 NDC # 46708-461-31Bottles of 500 NDC # 46708-461-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-461-10Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F). [See USP Controlled Room Temperature.] Protect from moisture.Amlodipine and valsartan tablets, USP are available as non-scored tablets containing amlodipine besylate equivalent to 5 mg, or 10 mg of amlodipine free-base with valsartan 160 mg or 320 mg, providing for the following available combinations: 5/160 mg, 10/160 mg, 5/320 mg and 10/320 mg.All strengths are packaged in bottles of 30, 90, 100 and 500 counts, and unit dose packages. 5/160 mg Tablets - dark yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L298’ on one side and plain on other side. Bottles of 30 NDC # 46708-458-30 Bottles of 90 NDC # 46708-458-90Bottles of 100 NDC # 46708-458-31Bottles of 500 NDC # 46708-458-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-458-1010/160 mg Tablets - light yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L300’ on one side and plain on other side. Bottles of 30 NDC # 46708-459-30 Bottles of 90 NDC # 46708-459-90Bottles of 100 NDC # 46708-459-31Bottles of 500 NDC # 46708-459-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-459-105/320 mg Tablets - dark yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L299’ on one side and plain on other side. Bottles of 30 NDC # 46708-460-30 Bottles of 90 NDC # 46708-460-90Bottles of 100 NDC # 46708-460-31Bottles of 500 NDC # 46708-460-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-460-1010/320 mg Tablets - light yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L301’ on one side and plain on other side. Bottles of 30 NDC # 46708-461-30 Bottles of 90 NDC # 46708-461-90Bottles of 100 NDC # 46708-461-31Bottles of 500 NDC # 46708-461-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-461-10Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F). [See USP Controlled Room Temperature.] Protect from moisture.Amlodipine and valsartan tablets, USP are available as non-scored tablets containing amlodipine besylate equivalent to 5 mg, or 10 mg of amlodipine free-base with valsartan 160 mg or 320 mg, providing for the following available combinations: 5/160 mg, 10/160 mg, 5/320 mg and 10/320 mg.All strengths are packaged in bottles of 30, 90, 100 and 500 counts, and unit dose packages. 5/160 mg Tablets - dark yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L298’ on one side and plain on other side. Bottles of 30 NDC # 46708-458-30 Bottles of 90 NDC # 46708-458-90Bottles of 100 NDC # 46708-458-31Bottles of 500 NDC # 46708-458-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-458-1010/160 mg Tablets - light yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L300’ on one side and plain on other side. Bottles of 30 NDC # 46708-459-30 Bottles of 90 NDC # 46708-459-90Bottles of 100 NDC # 46708-459-31Bottles of 500 NDC # 46708-459-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-459-105/320 mg Tablets - dark yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L299’ on one side and plain on other side. Bottles of 30 NDC # 46708-460-30 Bottles of 90 NDC # 46708-460-90Bottles of 100 NDC # 46708-460-31Bottles of 500 NDC # 46708-460-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-460-1010/320 mg Tablets - light yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L301’ on one side and plain on other side. Bottles of 30 NDC # 46708-461-30 Bottles of 90 NDC # 46708-461-90Bottles of 100 NDC # 46708-461-31Bottles of 500 NDC # 46708-461-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-461-10Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F). [See USP Controlled Room Temperature.] Protect from moisture.Amlodipine and valsartan tablets, USP are available as non-scored tablets containing amlodipine besylate equivalent to 5 mg, or 10 mg of amlodipine free-base with valsartan 160 mg or 320 mg, providing for the following available combinations: 5/160 mg, 10/160 mg, 5/320 mg and 10/320 mg.All strengths are packaged in bottles of 30, 90, 100 and 500 counts, and unit dose packages. 5/160 mg Tablets - dark yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L298’ on one side and plain on other side. Bottles of 30 NDC # 46708-458-30 Bottles of 90 NDC # 46708-458-90Bottles of 100 NDC # 46708-458-31Bottles of 500 NDC # 46708-458-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-458-1010/160 mg Tablets - light yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L300’ on one side and plain on other side. Bottles of 30 NDC # 46708-459-30 Bottles of 90 NDC # 46708-459-90Bottles of 100 NDC # 46708-459-31Bottles of 500 NDC # 46708-459-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-459-105/320 mg Tablets - dark yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L299’ on one side and plain on other side. Bottles of 30 NDC # 46708-460-30 Bottles of 90 NDC # 46708-460-90Bottles of 100 NDC # 46708-460-31Bottles of 500 NDC # 46708-460-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-460-1010/320 mg Tablets - light yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L301’ on one side and plain on other side. Bottles of 30 NDC # 46708-461-30 Bottles of 90 NDC # 46708-461-90Bottles of 100 NDC # 46708-461-31Bottles of 500 NDC # 46708-461-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-461-10Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F). [See USP Controlled Room Temperature.] Protect from moisture.Amlodipine and valsartan tablets, USP are available as non-scored tablets containing amlodipine besylate equivalent to 5 mg, or 10 mg of amlodipine free-base with valsartan 160 mg or 320 mg, providing for the following available combinations: 5/160 mg, 10/160 mg, 5/320 mg and 10/320 mg.All strengths are packaged in bottles of 30, 90, 100 and 500 counts, and unit dose packages. 5/160 mg Tablets - dark yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L298’ on one side and plain on other side. Bottles of 30 NDC # 46708-458-30 Bottles of 90 NDC # 46708-458-90Bottles of 100 NDC # 46708-458-31Bottles of 500 NDC # 46708-458-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-458-1010/160 mg Tablets - light yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L300’ on one side and plain on other side. Bottles of 30 NDC # 46708-459-30 Bottles of 90 NDC # 46708-459-90Bottles of 100 NDC # 46708-459-31Bottles of 500 NDC # 46708-459-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-459-105/320 mg Tablets - dark yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L299’ on one side and plain on other side. Bottles of 30 NDC # 46708-460-30 Bottles of 90 NDC # 46708-460-90Bottles of 100 NDC # 46708-460-31Bottles of 500 NDC # 46708-460-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-460-1010/320 mg Tablets - light yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L301’ on one side and plain on other side. Bottles of 30 NDC # 46708-461-30 Bottles of 90 NDC # 46708-461-90Bottles of 100 NDC # 46708-461-31Bottles of 500 NDC # 46708-461-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-461-10Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F). [See USP Controlled Room Temperature.] Protect from moisture.Amlodipine and valsartan tablets, USP are available as non-scored tablets containing amlodipine besylate equivalent to 5 mg, or 10 mg of amlodipine free-base with valsartan 160 mg or 320 mg, providing for the following available combinations: 5/160 mg, 10/160 mg, 5/320 mg and 10/320 mg.All strengths are packaged in bottles of 30, 90, 100 and 500 counts, and unit dose packages. 5/160 mg Tablets - dark yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L298’ on one side and plain on other side. Bottles of 30 NDC # 46708-458-30 Bottles of 90 NDC # 46708-458-90Bottles of 100 NDC # 46708-458-31Bottles of 500 NDC # 46708-458-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-458-1010/160 mg Tablets - light yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L300’ on one side and plain on other side. Bottles of 30 NDC # 46708-459-30 Bottles of 90 NDC # 46708-459-90Bottles of 100 NDC # 46708-459-31Bottles of 500 NDC # 46708-459-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-459-105/320 mg Tablets - dark yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L299’ on one side and plain on other side. Bottles of 30 NDC # 46708-460-30 Bottles of 90 NDC # 46708-460-90Bottles of 100 NDC # 46708-460-31Bottles of 500 NDC # 46708-460-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-460-1010/320 mg Tablets - light yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L301’ on one side and plain on other side. Bottles of 30 NDC # 46708-461-30 Bottles of 90 NDC # 46708-461-90Bottles of 100 NDC # 46708-461-31Bottles of 500 NDC # 46708-461-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-461-10Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F). [See USP Controlled Room Temperature.] Protect from moisture.Amlodipine and valsartan tablets, USP are available as non-scored tablets containing amlodipine besylate equivalent to 5 mg, or 10 mg of amlodipine free-base with valsartan 160 mg or 320 mg, providing for the following available combinations: 5/160 mg, 10/160 mg, 5/320 mg and 10/320 mg.All strengths are packaged in bottles of 30, 90, 100 and 500 counts, and unit dose packages. 5/160 mg Tablets - dark yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L298’ on one side and plain on other side. Bottles of 30 NDC # 46708-458-30 Bottles of 90 NDC # 46708-458-90Bottles of 100 NDC # 46708-458-31Bottles of 500 NDC # 46708-458-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-458-1010/160 mg Tablets - light yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L300’ on one side and plain on other side. Bottles of 30 NDC # 46708-459-30 Bottles of 90 NDC # 46708-459-90Bottles of 100 NDC # 46708-459-31Bottles of 500 NDC # 46708-459-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-459-105/320 mg Tablets - dark yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L299’ on one side and plain on other side. Bottles of 30 NDC # 46708-460-30 Bottles of 90 NDC # 46708-460-90Bottles of 100 NDC # 46708-460-31Bottles of 500 NDC # 46708-460-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-460-1010/320 mg Tablets - light yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L301’ on one side and plain on other side. Bottles of 30 NDC # 46708-461-30 Bottles of 90 NDC # 46708-461-90Bottles of 100 NDC # 46708-461-31Bottles of 500 NDC # 46708-461-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-461-10Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F). [See USP Controlled Room Temperature.] Protect from moisture.Amlodipine and valsartan tablets, USP are available as non-scored tablets containing amlodipine besylate equivalent to 5 mg, or 10 mg of amlodipine free-base with valsartan 160 mg or 320 mg, providing for the following available combinations: 5/160 mg, 10/160 mg, 5/320 mg and 10/320 mg.All strengths are packaged in bottles of 30, 90, 100 and 500 counts, and unit dose packages. 5/160 mg Tablets - dark yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L298’ on one side and plain on other side. Bottles of 30 NDC # 46708-458-30 Bottles of 90 NDC # 46708-458-90Bottles of 100 NDC # 46708-458-31Bottles of 500 NDC # 46708-458-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-458-1010/160 mg Tablets - light yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L300’ on one side and plain on other side. Bottles of 30 NDC # 46708-459-30 Bottles of 90 NDC # 46708-459-90Bottles of 100 NDC # 46708-459-31Bottles of 500 NDC # 46708-459-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-459-105/320 mg Tablets - dark yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L299’ on one side and plain on other side. Bottles of 30 NDC # 46708-460-30 Bottles of 90 NDC # 46708-460-90Bottles of 100 NDC # 46708-460-31Bottles of 500 NDC # 46708-460-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-460-1010/320 mg Tablets - light yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L301’ on one side and plain on other side. Bottles of 30 NDC # 46708-461-30 Bottles of 90 NDC # 46708-461-90Bottles of 100 NDC # 46708-461-31Bottles of 500 NDC # 46708-461-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-461-10Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F). [See USP Controlled Room Temperature.] Protect from moisture.Amlodipine and valsartan tablets, USP are available as non-scored tablets containing amlodipine besylate equivalent to 5 mg, or 10 mg of amlodipine free-base with valsartan 160 mg or 320 mg, providing for the following available combinations: 5/160 mg, 10/160 mg, 5/320 mg and 10/320 mg.All strengths are packaged in bottles of 30, 90, 100 and 500 counts, and unit dose packages. 5/160 mg Tablets - dark yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L298’ on one side and plain on other side. Bottles of 30 NDC # 46708-458-30 Bottles of 90 NDC # 46708-458-90Bottles of 100 NDC # 46708-458-31Bottles of 500 NDC # 46708-458-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-458-1010/160 mg Tablets - light yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L300’ on one side and plain on other side. Bottles of 30 NDC # 46708-459-30 Bottles of 90 NDC # 46708-459-90Bottles of 100 NDC # 46708-459-31Bottles of 500 NDC # 46708-459-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-459-105/320 mg Tablets - dark yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L299’ on one side and plain on other side. Bottles of 30 NDC # 46708-460-30 Bottles of 90 NDC # 46708-460-90Bottles of 100 NDC # 46708-460-31Bottles of 500 NDC # 46708-460-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-460-1010/320 mg Tablets - light yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L301’ on one side and plain on other side. Bottles of 30 NDC # 46708-461-30 Bottles of 90 NDC # 46708-461-90Bottles of 100 NDC # 46708-461-31Bottles of 500 NDC # 46708-461-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-461-10Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F). [See USP Controlled Room Temperature.] Protect from moisture.Amlodipine and valsartan tablets, USP are available as non-scored tablets containing amlodipine besylate equivalent to 5 mg, or 10 mg of amlodipine free-base with valsartan 160 mg or 320 mg, providing for the following available combinations: 5/160 mg, 10/160 mg, 5/320 mg and 10/320 mg.All strengths are packaged in bottles of 30, 90, 100 and 500 counts, and unit dose packages. 5/160 mg Tablets - dark yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L298’ on one side and plain on other side. Bottles of 30 NDC # 46708-458-30 Bottles of 90 NDC # 46708-458-90Bottles of 100 NDC # 46708-458-31Bottles of 500 NDC # 46708-458-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-458-1010/160 mg Tablets - light yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L300’ on one side and plain on other side. Bottles of 30 NDC # 46708-459-30 Bottles of 90 NDC # 46708-459-90Bottles of 100 NDC # 46708-459-31Bottles of 500 NDC # 46708-459-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-459-105/320 mg Tablets - dark yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L299’ on one side and plain on other side. Bottles of 30 NDC # 46708-460-30 Bottles of 90 NDC # 46708-460-90Bottles of 100 NDC # 46708-460-31Bottles of 500 NDC # 46708-460-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-460-1010/320 mg Tablets - light yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L301’ on one side and plain on other side. Bottles of 30 NDC # 46708-461-30 Bottles of 90 NDC # 46708-461-90Bottles of 100 NDC # 46708-461-31Bottles of 500 NDC # 46708-461-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-461-10Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F). [See USP Controlled Room Temperature.] Protect from moisture.Amlodipine and valsartan tablets, USP are available as non-scored tablets containing amlodipine besylate equivalent to 5 mg, or 10 mg of amlodipine free-base with valsartan 160 mg or 320 mg, providing for the following available combinations: 5/160 mg, 10/160 mg, 5/320 mg and 10/320 mg.All strengths are packaged in bottles of 30, 90, 100 and 500 counts, and unit dose packages. 5/160 mg Tablets - dark yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L298’ on one side and plain on other side. Bottles of 30 NDC # 46708-458-30 Bottles of 90 NDC # 46708-458-90Bottles of 100 NDC # 46708-458-31Bottles of 500 NDC # 46708-458-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-458-1010/160 mg Tablets - light yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L300’ on one side and plain on other side. Bottles of 30 NDC # 46708-459-30 Bottles of 90 NDC # 46708-459-90Bottles of 100 NDC # 46708-459-31Bottles of 500 NDC # 46708-459-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-459-105/320 mg Tablets - dark yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L299’ on one side and plain on other side. Bottles of 30 NDC # 46708-460-30 Bottles of 90 NDC # 46708-460-90Bottles of 100 NDC # 46708-460-31Bottles of 500 NDC # 46708-460-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-460-1010/320 mg Tablets - light yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L301’ on one side and plain on other side. Bottles of 30 NDC # 46708-461-30 Bottles of 90 NDC # 46708-461-90Bottles of 100 NDC # 46708-461-31Bottles of 500 NDC # 46708-461-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-461-10Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F). [See USP Controlled Room Temperature.] Protect from moisture.Amlodipine and valsartan tablets, USP are available as non-scored tablets containing amlodipine besylate equivalent to 5 mg, or 10 mg of amlodipine free-base with valsartan 160 mg or 320 mg, providing for the following available combinations: 5/160 mg, 10/160 mg, 5/320 mg and 10/320 mg.All strengths are packaged in bottles of 30, 90, 100 and 500 counts, and unit dose packages. 5/160 mg Tablets - dark yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L298’ on one side and plain on other side. Bottles of 30 NDC # 46708-458-30 Bottles of 90 NDC # 46708-458-90Bottles of 100 NDC # 46708-458-31Bottles of 500 NDC # 46708-458-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-458-1010/160 mg Tablets - light yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L300’ on one side and plain on other side. Bottles of 30 NDC # 46708-459-30 Bottles of 90 NDC # 46708-459-90Bottles of 100 NDC # 46708-459-31Bottles of 500 NDC # 46708-459-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-459-105/320 mg Tablets - dark yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L299’ on one side and plain on other side. Bottles of 30 NDC # 46708-460-30 Bottles of 90 NDC # 46708-460-90Bottles of 100 NDC # 46708-460-31Bottles of 500 NDC # 46708-460-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-460-1010/320 mg Tablets - light yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L301’ on one side and plain on other side. Bottles of 30 NDC # 46708-461-30 Bottles of 90 NDC # 46708-461-90Bottles of 100 NDC # 46708-461-31Bottles of 500 NDC # 46708-461-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-461-10Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F). [See USP Controlled Room Temperature.] Protect from moisture.Amlodipine and valsartan tablets, USP are available as non-scored tablets containing amlodipine besylate equivalent to 5 mg, or 10 mg of amlodipine free-base with valsartan 160 mg or 320 mg, providing for the following available combinations: 5/160 mg, 10/160 mg, 5/320 mg and 10/320 mg.All strengths are packaged in bottles of 30, 90, 100 and 500 counts, and unit dose packages. 5/160 mg Tablets - dark yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L298’ on one side and plain on other side. Bottles of 30 NDC # 46708-458-30 Bottles of 90 NDC # 46708-458-90Bottles of 100 NDC # 46708-458-31Bottles of 500 NDC # 46708-458-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-458-1010/160 mg Tablets - light yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L300’ on one side and plain on other side. Bottles of 30 NDC # 46708-459-30 Bottles of 90 NDC # 46708-459-90Bottles of 100 NDC # 46708-459-31Bottles of 500 NDC # 46708-459-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-459-105/320 mg Tablets - dark yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L299’ on one side and plain on other side. Bottles of 30 NDC # 46708-460-30 Bottles of 90 NDC # 46708-460-90Bottles of 100 NDC # 46708-460-31Bottles of 500 NDC # 46708-460-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-460-1010/320 mg Tablets - light yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L301’ on one side and plain on other side. Bottles of 30 NDC # 46708-461-30 Bottles of 90 NDC # 46708-461-90Bottles of 100 NDC # 46708-461-31Bottles of 500 NDC # 46708-461-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-461-10Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F). [See USP Controlled Room Temperature.] Protect from moisture.Amlodipine and valsartan tablets, USP are available as non-scored tablets containing amlodipine besylate equivalent to 5 mg, or 10 mg of amlodipine free-base with valsartan 160 mg or 320 mg, providing for the following available combinations: 5/160 mg, 10/160 mg, 5/320 mg and 10/320 mg.All strengths are packaged in bottles of 30, 90, 100 and 500 counts, and unit dose packages. 5/160 mg Tablets - dark yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L298’ on one side and plain on other side. Bottles of 30 NDC # 46708-458-30 Bottles of 90 NDC # 46708-458-90Bottles of 100 NDC # 46708-458-31Bottles of 500 NDC # 46708-458-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-458-1010/160 mg Tablets - light yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L300’ on one side and plain on other side. Bottles of 30 NDC # 46708-459-30 Bottles of 90 NDC # 46708-459-90Bottles of 100 NDC # 46708-459-31Bottles of 500 NDC # 46708-459-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-459-105/320 mg Tablets - dark yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L299’ on one side and plain on other side. Bottles of 30 NDC # 46708-460-30 Bottles of 90 NDC # 46708-460-90Bottles of 100 NDC # 46708-460-31Bottles of 500 NDC # 46708-460-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-460-1010/320 mg Tablets - light yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L301’ on one side and plain on other side. Bottles of 30 NDC # 46708-461-30 Bottles of 90 NDC # 46708-461-90Bottles of 100 NDC # 46708-461-31Bottles of 500 NDC # 46708-461-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-461-10Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F). [See USP Controlled Room Temperature.] Protect from moisture.Amlodipine and valsartan tablets, USP are available as non-scored tablets containing amlodipine besylate equivalent to 5 mg, or 10 mg of amlodipine free-base with valsartan 160 mg or 320 mg, providing for the following available combinations: 5/160 mg, 10/160 mg, 5/320 mg and 10/320 mg.All strengths are packaged in bottles of 30, 90, 100 and 500 counts, and unit dose packages. 5/160 mg Tablets - dark yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L298’ on one side and plain on other side. Bottles of 30 NDC # 46708-458-30 Bottles of 90 NDC # 46708-458-90Bottles of 100 NDC # 46708-458-31Bottles of 500 NDC # 46708-458-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-458-1010/160 mg Tablets - light yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L300’ on one side and plain on other side. Bottles of 30 NDC # 46708-459-30 Bottles of 90 NDC # 46708-459-90Bottles of 100 NDC # 46708-459-31Bottles of 500 NDC # 46708-459-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-459-105/320 mg Tablets - dark yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L299’ on one side and plain on other side. Bottles of 30 NDC # 46708-460-30 Bottles of 90 NDC # 46708-460-90Bottles of 100 NDC # 46708-460-31Bottles of 500 NDC # 46708-460-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-460-1010/320 mg Tablets - light yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L301’ on one side and plain on other side. Bottles of 30 NDC # 46708-461-30 Bottles of 90 NDC # 46708-461-90Bottles of 100 NDC # 46708-461-31Bottles of 500 NDC # 46708-461-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-461-10Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F). [See USP Controlled Room Temperature.] Protect from moisture.Amlodipine and valsartan tablets, USP are available as non-scored tablets containing amlodipine besylate equivalent to 5 mg, or 10 mg of amlodipine free-base with valsartan 160 mg or 320 mg, providing for the following available combinations: 5/160 mg, 10/160 mg, 5/320 mg and 10/320 mg.All strengths are packaged in bottles of 30, 90, 100 and 500 counts, and unit dose packages. 5/160 mg Tablets - dark yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L298’ on one side and plain on other side. Bottles of 30 NDC # 46708-458-30 Bottles of 90 NDC # 46708-458-90Bottles of 100 NDC # 46708-458-31Bottles of 500 NDC # 46708-458-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-458-1010/160 mg Tablets - light yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L300’ on one side and plain on other side. Bottles of 30 NDC # 46708-459-30 Bottles of 90 NDC # 46708-459-90Bottles of 100 NDC # 46708-459-31Bottles of 500 NDC # 46708-459-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-459-105/320 mg Tablets - dark yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L299’ on one side and plain on other side. Bottles of 30 NDC # 46708-460-30 Bottles of 90 NDC # 46708-460-90Bottles of 100 NDC # 46708-460-31Bottles of 500 NDC # 46708-460-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-460-1010/320 mg Tablets - light yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L301’ on one side and plain on other side. Bottles of 30 NDC # 46708-461-30 Bottles of 90 NDC # 46708-461-90Bottles of 100 NDC # 46708-461-31Bottles of 500 NDC # 46708-461-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-461-10Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F). [See USP Controlled Room Temperature.] Protect from moisture.Amlodipine and valsartan tablets, USP are available as non-scored tablets containing amlodipine besylate equivalent to 5 mg, or 10 mg of amlodipine free-base with valsartan 160 mg or 320 mg, providing for the following available combinations: 5/160 mg, 10/160 mg, 5/320 mg and 10/320 mg.All strengths are packaged in bottles of 30, 90, 100 and 500 counts, and unit dose packages. 5/160 mg Tablets - dark yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L298’ on one side and plain on other side. Bottles of 30 NDC # 46708-458-30 Bottles of 90 NDC # 46708-458-90Bottles of 100 NDC # 46708-458-31Bottles of 500 NDC # 46708-458-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-458-1010/160 mg Tablets - light yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L300’ on one side and plain on other side. Bottles of 30 NDC # 46708-459-30 Bottles of 90 NDC # 46708-459-90Bottles of 100 NDC # 46708-459-31Bottles of 500 NDC # 46708-459-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-459-105/320 mg Tablets - dark yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L299’ on one side and plain on other side. Bottles of 30 NDC # 46708-460-30 Bottles of 90 NDC # 46708-460-90Bottles of 100 NDC # 46708-460-31Bottles of 500 NDC # 46708-460-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-460-1010/320 mg Tablets - light yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L301’ on one side and plain on other side. Bottles of 30 NDC # 46708-461-30 Bottles of 90 NDC # 46708-461-90Bottles of 100 NDC # 46708-461-31Bottles of 500 NDC # 46708-461-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-461-10Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F). [See USP Controlled Room Temperature.] Protect from moisture.Amlodipine and valsartan tablets, USP are available as non-scored tablets containing amlodipine besylate equivalent to 5 mg, or 10 mg of amlodipine free-base with valsartan 160 mg or 320 mg, providing for the following available combinations: 5/160 mg, 10/160 mg, 5/320 mg and 10/320 mg.All strengths are packaged in bottles of 30, 90, 100 and 500 counts, and unit dose packages. 5/160 mg Tablets - dark yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L298’ on one side and plain on other side. Bottles of 30 NDC # 46708-458-30 Bottles of 90 NDC # 46708-458-90Bottles of 100 NDC # 46708-458-31Bottles of 500 NDC # 46708-458-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-458-1010/160 mg Tablets - light yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L300’ on one side and plain on other side. Bottles of 30 NDC # 46708-459-30 Bottles of 90 NDC # 46708-459-90Bottles of 100 NDC # 46708-459-31Bottles of 500 NDC # 46708-459-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-459-105/320 mg Tablets - dark yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L299’ on one side and plain on other side. Bottles of 30 NDC # 46708-460-30 Bottles of 90 NDC # 46708-460-90Bottles of 100 NDC # 46708-460-31Bottles of 500 NDC # 46708-460-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-460-1010/320 mg Tablets - light yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L301’ on one side and plain on other side. Bottles of 30 NDC # 46708-461-30 Bottles of 90 NDC # 46708-461-90Bottles of 100 NDC # 46708-461-31Bottles of 500 NDC # 46708-461-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-461-10Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F). [See USP Controlled Room Temperature.] Protect from moisture.Amlodipine and valsartan tablets, USP are available as non-scored tablets containing amlodipine besylate equivalent to 5 mg, or 10 mg of amlodipine free-base with valsartan 160 mg or 320 mg, providing for the following available combinations: 5/160 mg, 10/160 mg, 5/320 mg and 10/320 mg.All strengths are packaged in bottles of 30, 90, 100 and 500 counts, and unit dose packages. 5/160 mg Tablets - dark yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L298’ on one side and plain on other side. Bottles of 30 NDC # 46708-458-30 Bottles of 90 NDC # 46708-458-90Bottles of 100 NDC # 46708-458-31Bottles of 500 NDC # 46708-458-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-458-1010/160 mg Tablets - light yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L300’ on one side and plain on other side. Bottles of 30 NDC # 46708-459-30 Bottles of 90 NDC # 46708-459-90Bottles of 100 NDC # 46708-459-31Bottles of 500 NDC # 46708-459-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-459-105/320 mg Tablets - dark yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L299’ on one side and plain on other side. Bottles of 30 NDC # 46708-460-30 Bottles of 90 NDC # 46708-460-90Bottles of 100 NDC # 46708-460-31Bottles of 500 NDC # 46708-460-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-460-1010/320 mg Tablets - light yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L301’ on one side and plain on other side. Bottles of 30 NDC # 46708-461-30 Bottles of 90 NDC # 46708-461-90Bottles of 100 NDC # 46708-461-31Bottles of 500 NDC # 46708-461-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-461-10Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F). [See USP Controlled Room Temperature.] Protect from moisture.Amlodipine and valsartan tablets, USP are available as non-scored tablets containing amlodipine besylate equivalent to 5 mg, or 10 mg of amlodipine free-base with valsartan 160 mg or 320 mg, providing for the following available combinations: 5/160 mg, 10/160 mg, 5/320 mg and 10/320 mg.All strengths are packaged in bottles of 30, 90, 100 and 500 counts, and unit dose packages. 5/160 mg Tablets - dark yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L298’ on one side and plain on other side. Bottles of 30 NDC # 46708-458-30 Bottles of 90 NDC # 46708-458-90Bottles of 100 NDC # 46708-458-31Bottles of 500 NDC # 46708-458-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-458-1010/160 mg Tablets - light yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L300’ on one side and plain on other side. Bottles of 30 NDC # 46708-459-30 Bottles of 90 NDC # 46708-459-90Bottles of 100 NDC # 46708-459-31Bottles of 500 NDC # 46708-459-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-459-105/320 mg Tablets - dark yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L299’ on one side and plain on other side. Bottles of 30 NDC # 46708-460-30 Bottles of 90 NDC # 46708-460-90Bottles of 100 NDC # 46708-460-31Bottles of 500 NDC # 46708-460-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-460-1010/320 mg Tablets - light yellow, oval-shaped, biconvex, film coated tablets debossed with ‘L301’ on one side and plain on other side. Bottles of 30 NDC # 46708-461-30 Bottles of 90 NDC # 46708-461-90Bottles of 100 NDC # 46708-461-31Bottles of 500 NDC # 46708-461-71 100 (10 x 10) Tablets Unit Dose Blister Pack NDC # 46708-461-10Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F). [See USP Controlled Room Temperature.] Protect from moisture.
Clinical Information
Chemical Structure
No Image foundClinical Pharmacology
Non-Clinical Toxicology
The hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents, some azoles, and other drugs that are highly protein bound, salicylates, sulfonamides, chloramphenicol, probenecid, coumarins, monoamine oxidase inhibitors, quinolones and beta adrenergic blocking agents. When such drugs are administered to a patient receiving glipizide, the patient should be observed closely for hypoglycemia. When such drugs are withdrawn from a patient receiving glipizide, the patient should be observed closely for loss of control. binding studies with human serum proteins indicate that glipizide binds differently than tolbutamide and does not interact with salicylate or dicumarol. However, caution must be exercised in extrapolating these findings to the clinical situation and in the use of glipizide with these drugs.Certain drugs tend to produce hyperglycemia and may lead to loss of control. These drugs include the thiazides and other diuretics, corticosteroids, phenothiazines, thyroid products, estrogens, oral contraceptives, phenytoin, nicotinic acid, sympathomimetics, calcium channel blocking drugs, and isoniazid. When such drugs are administered to a patient receiving glipizide, the patient should be closely observed for loss of control. When such drugs are withdrawn from a patient receiving glipizide, the patient should be observed closely for hypoglycemia.
A potential interaction between oral miconazole and oral hypoglycemic agents leading to severe hypoglycemia has been reported. Whether this interaction also occurs with the intravenous, topical, or vaginal preparations of miconazole is not known. The effect of concomitant administration of fluconazole and glipizide was reported in a placebo-controlled crossover study in normal volunteers. All subjects received glipizide alone and following treatment with 100 mg of fluconazole as a single daily oral dose for 7 days. The mean percentage increase in the glipizide AUC after fluconazole administration was 56.9% (range: 35 to 81).
In studies assessing the effect of colesevelam on the pharmacokinetics of glipizide ER in healthy volunteers, reductions in glipizide AUC and C of 12% and 13%, respectively were observed when colesevelam was coadministered with glipizide ER. When glipizide ER was administered 4 hours prior to colesevelam, there was no significant change in glipizide AUC or C , -4% and 0%, respectively. Therefore, glipizide should be administered at least 4 hours prior to colesevelam to ensure that colesevelam does not reduce the absorption of glipizide.
Pregnancy Category D
Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death. Resulting oligohydramnios can be associated with fetal lung hypoplasia and skeletal deformations. Potential neonatal adverse effects include skull hypoplasia, anuria, hypotension, renal failure, and death. When pregnancy is detected, discontinue amlodipine and valsartan tablets as soon as possible .
Reference
This information is obtained from the National Institute of Health's Standard Packaging Label drug database.
"https://dailymed.nlm.nih.gov/dailymed/"
While we update our database periodically, we cannot guarantee it is always updated to the latest version.
Review
Professional
Clonazepam Description Each single-scored tablet, for oral administration, contains 0.5 mg, 1 mg, or 2 mg Clonazepam, USP, a benzodiazepine. Each tablet also contains corn starch, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and povidone. Clonazepam tablets USP 0.5 mg contain Yellow D&C No. 10 Aluminum Lake. Clonazepam tablets USP 1 mg contain Yellow D&C No. 10 Aluminum Lake, as well as FD&C Blue No. 1 Aluminum Lake. Chemically, Clonazepam, USP is 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder. It has the following structural formula: C15H10ClN3O3 M.W. 315.72Tips
Tips
Interactions
Interactions
A total of 440 drugs (1549 brand and generic names) are known to interact with Imbruvica (ibrutinib). 228 major drug interactions (854 brand and generic names) 210 moderate drug interactions (691 brand and generic names) 2 minor drug interactions (4 brand and generic names) Show all medications in the database that may interact with Imbruvica (ibrutinib).